Piper Sandler Upgrades AMAG Pharmaceuticals (AMAG) to Neutral

October 1, 2020 12:22 PM EDT
Get Alerts AMAG Hot Sheet
Price: $13.75 --0%

Rating Summary:
    8 Buy, 11 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 10 | New: 33
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Piper Sandler analyst Christopher J. Raymond upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Underweight to Neutral with a price target of $13.75 (from $8.00).

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

Shares of AMAG Pharmaceuticals closed at $9.40 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades